Tek antagonists
US7067475B2 · kind B2 · utility
27Cited by
7References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 3, 2003 |
| Grant date | Jun 27, 2006 |
| Priority date | — |
| Expiry date | Jun 5, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides Tek antagonists and methods of inhibiting angiogenesis in a mammal by administering Tek antagonists. The methods are particularly useful in treating diseases or conditions mediated by angiogenesis, such as solid tumors and diseases or conditions characterized by ocular neovascularization.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.